Analyst Ratings For NYSE:THC – Tenet Healthcare (NYSE:THC)
Today, Citigroup reiterated its Buy rating on NYSE:THC – Tenet Healthcare (NYSE:THC) with a price target of $37.00.
Some recent analyst ratings include
- 5/8/2018-Citigroup Reiterated Rating of Buy.
- 4/17/2018-SunTrust Banks Reiterated Rating of Hold.
- 3/22/2018-Mizuho Reiterated Rating of Buy.
- On 3/9/2018 Ashish Dave, Director, sold 75,000 with an average share price of $1.40 per share and the total transaction amounting to $105,000.00.
- On 2/5/2018 George Fredrick Smitherman, Director, sold 39,000 with an average share price of $0.39 per share and the total transaction amounting to $15,210.00.
- On 1/30/2018 George Fredrick Smitherman, Director, sold 14,300 with an average share price of $2.02 per share and the total transaction amounting to $28,886.00.
- On 1/25/2018 George Fredrick Smitherman, Director, bought 125,000 with an average share price of $38.50 per share and the total transaction amounting to $4,812,500.00.
- On 1/15/2018 George Fredrick Smitherman, Director, sold 1,300 with an average share price of $38.50 per share and the total transaction amounting to $50,050.00.
- On 11/11/2016 Ronald A Rittenmeyer, Director, bought 15,000 with an average share price of $14.35 per share and the total transaction amounting to $215,250.00.
- On 11/9/2016 Peter M Wilver, Director, bought 5,000 with an average share price of $15.19 per share and the total transaction amounting to $75,950.00.
Recent Trading Activity for NYSE:THC – Tenet Healthcare (NYSE:THC)
Shares of NYSE:THC – Tenet Healthcare closed the previous trading session at 31.92 up +0.05 0.16% with shares trading hands.